Latest News

Omicron hospitalisation risk around one third of Delta, UK analysis shows

0
© Reuters. People wearing face masks sanitise hands, amid the spread of the coronavirus disease (COVID-19), at the main entrance of the Royal London Hospital, in London, Britain December 31, 2021. REUTERS/May James

LONDON (Reuters) -The risk of hospitalisation with the Omicron variant of coronavirus is about one-third that of the Delta variant, according to British analysis of more than a million cases of both types in recent weeks.

Britain is experiencing a surge in COVID-19 cases driven by the highly-transmissible Omicron variant, with record daily infection levels being reported. While hospital admissions have started to rise, the government has said it believes the new variant is milder than the Delta variant.

The number of patients needing mechanical ventilation beds has also remained steady through December, unlike previous peaks in the pandemic.

The analysis was published by the UK Health Security Agency, after it worked alongside Cambridge University MRC Biostatistics unit to analyse 528,176 Omicron cases and 573,012 Delta cases.

It also found that vaccines can work well against Omicron.

“In this analysis, the risk of hospitalisation is lower for Omicron cases with symptomatic or asymptomatic infection after 2 and 3 doses of vaccine, with an 81% … reduction in the risk of hospitalisation after 3 doses compared to unvaccinated Omicron cases,” the UKHSA said.

Susan Hopkins, Chief Medical Adviser at UKHSA, said the analysis was in keeping with other encouraging signs on Omicron but said the health service could still struggle with such high transmission rates.

“It remains too early to draw any definitive conclusions on hospital severity, and the increased transmissibility of Omicron and the rising cases in the over 60s population in England means it remains highly likely that there will be significant pressure on the NHS in coming weeks,” she said.

Omicron hospitalisation risk around one third of Delta, UK analysis shows

Disclaimer:Fusion Mediawould like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Lawler: More on the CoreLogic Home Investor Activity Report

Previous article

U.S. equity funds receive big inflows as investors downgrade Omicron impact -Lipper

Next article

You may also like

Comments

Leave a reply

Your email address will not be published.

More in Latest News